title: The case for a new national program for the development of cancer therapeutics.
authors.affiliation: International Network for Cancer Treatment and Research, United States Branch, Bryn Mawr, PA, USA. philschein1@home.com
authors.forename: P S
authors.initials: PS
authors.lastname: Schein
mesh_terms: D014487:Centers for Medicare and Medicaid Services, U.S.; D017277:Drug Approval; D015195:Drug Design; D004345:Drug Industry; D005069:Evaluation Studies as Topic; D006801:Humans; D007373:Interinstitutional Relations; D009313:National Health Programs / Q000458:organization & administration*; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy*; D010344:Patient Advocacy; D012106:Research / Q000458:organization & administration*; D012109:Research Support as Topic / Q000458:organization & administration*; D014481:United States; D014486:United States Food and Drug Administration